1. Home
  2. MIST vs MAA Comparison

MIST vs MAA Comparison

Compare MIST & MAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • MAA
  • Stock Information
  • Founded
  • MIST 2003
  • MAA 1977
  • Country
  • MIST Canada
  • MAA United States
  • Employees
  • MIST N/A
  • MAA N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • MAA Real Estate Investment Trusts
  • Sector
  • MIST Health Care
  • MAA Real Estate
  • Exchange
  • MIST Nasdaq
  • MAA Nasdaq
  • Market Cap
  • MIST 145.3M
  • MAA 16.6B
  • IPO Year
  • MIST N/A
  • MAA 1994
  • Fundamental
  • Price
  • MIST $1.94
  • MAA $139.50
  • Analyst Decision
  • MIST Strong Buy
  • MAA Buy
  • Analyst Count
  • MIST 3
  • MAA 18
  • Target Price
  • MIST $6.33
  • MAA $162.50
  • AVG Volume (30 Days)
  • MIST 1.2M
  • MAA 702.6K
  • Earning Date
  • MIST 11-11-2025
  • MAA 10-29-2025
  • Dividend Yield
  • MIST N/A
  • MAA 4.34%
  • EPS Growth
  • MIST N/A
  • MAA 10.39
  • EPS
  • MIST N/A
  • MAA 4.85
  • Revenue
  • MIST N/A
  • MAA $2,200,155,000.00
  • Revenue This Year
  • MIST N/A
  • MAA $1.96
  • Revenue Next Year
  • MIST N/A
  • MAA $3.13
  • P/E Ratio
  • MIST N/A
  • MAA $28.79
  • Revenue Growth
  • MIST N/A
  • MAA 1.19
  • 52 Week Low
  • MIST $0.63
  • MAA $137.32
  • 52 Week High
  • MIST $2.75
  • MAA $173.38
  • Technical
  • Relative Strength Index (RSI)
  • MIST 64.09
  • MAA 40.94
  • Support Level
  • MIST $1.75
  • MAA $139.01
  • Resistance Level
  • MIST $2.06
  • MAA $145.80
  • Average True Range (ATR)
  • MIST 0.09
  • MAA 2.44
  • MACD
  • MIST 0.02
  • MAA -0.34
  • Stochastic Oscillator
  • MIST 66.67
  • MAA 6.62

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.

Share on Social Networks: